Isthmus Partners LLC Cuts Stock Holdings in Utah Medical Products, Inc. $UTMD

Isthmus Partners LLC lowered its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 75.9% during the fourth quarter, Holdings Channel reports. The fund owned 9,233 shares of the medical instruments supplier’s stock after selling 29,050 shares during the period. Isthmus Partners LLC’s holdings in Utah Medical Products were worth $517,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Dimensional Fund Advisors LP increased its position in shares of Utah Medical Products by 1.3% during the third quarter. Dimensional Fund Advisors LP now owns 200,032 shares of the medical instruments supplier’s stock worth $12,596,000 after acquiring an additional 2,566 shares during the period. Geode Capital Management LLC increased its position in shares of Utah Medical Products by 6.5% during the second quarter. Geode Capital Management LLC now owns 114,816 shares of the medical instruments supplier’s stock worth $6,537,000 after acquiring an additional 7,040 shares during the period. Cardinal Capital Management increased its position in shares of Utah Medical Products by 1.9% during the fourth quarter. Cardinal Capital Management now owns 24,836 shares of the medical instruments supplier’s stock worth $1,394,000 after acquiring an additional 459 shares during the period. Bard Associates Inc. increased its position in shares of Utah Medical Products by 3.8% during the third quarter. Bard Associates Inc. now owns 20,771 shares of the medical instruments supplier’s stock worth $1,314,000 after acquiring an additional 764 shares during the period. Finally, Qube Research & Technologies Ltd increased its position in shares of Utah Medical Products by 7.6% during the third quarter. Qube Research & Technologies Ltd now owns 13,488 shares of the medical instruments supplier’s stock worth $849,000 after acquiring an additional 948 shares during the period. Hedge funds and other institutional investors own 69.60% of the company’s stock.

Utah Medical Products Trading Down 0.6%

Shares of UTMD stock opened at $63.34 on Friday. The firm has a fifty day moving average price of $65.09 and a 200 day moving average price of $61.40. The company has a market cap of $201.42 million, a P/E ratio of 18.74 and a beta of 0.37. Utah Medical Products, Inc. has a 12 month low of $52.00 and a 12 month high of $71.81.

Utah Medical Products (NASDAQ:UTMD) last issued its earnings results on Thursday, April 23rd. The medical instruments supplier reported $0.82 EPS for the quarter. The firm had revenue of $8.72 million during the quarter. Utah Medical Products had a net margin of 28.90% and a return on equity of 9.13%.

Utah Medical Products Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 3rd. Investors of record on Wednesday, June 17th will be paid a dividend of $0.31 per share. The ex-dividend date is Wednesday, June 17th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 2.0%. Utah Medical Products’s payout ratio is presently 36.69%.

Analyst Ratings Changes

Separately, Weiss Ratings raised Utah Medical Products from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, February 25th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

About Utah Medical Products

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single?use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non?invasive monitoring products used in acute and long?term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end?tidal carbon dioxide (CO?).